BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-federspiel E, França Jr MC, Martinez ARM, Camdessanché J, Antoine J. Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies. J Neurol Neurosurg Psychiatry 2019;91:49-57. [DOI: 10.1136/jnnp-2019-321849] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Moritz CP, Do L, Tholance Y, Vallayer P, Rogemond V, Joubert B, Ferraud K, La Marca C, Camdessanché J, Honnorat J, Antoine J. Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies. Front Immunol 2022;13:972161. [DOI: 10.3389/fimmu.2022.972161] [Reference Citation Analysis]
2 Bayraktutar BN, Atocha V, Farhad K, Soto O, Hamrah P. Autoantibodies Against Trisulfated Heparin Disaccharide and Fibroblast Growth Factor Receptor-3 May Play a Role in the Pathogenesis of Neuropathic Corneal Pain. Cornea 2022. [PMID: 36256257 DOI: 10.1097/ICO.0000000000003142] [Reference Citation Analysis]
3 Appenzeller S, Andrade de Oliveira S, Bombini MF, Sepresse SR, Reis F, Cavalcante França Junior M. Neuropsychiatric manifestations in primary Sjogren syndrome. Expert Rev Clin Immunol 2022. [PMID: 36001085 DOI: 10.1080/1744666X.2022.2117159] [Reference Citation Analysis]
4 Antoine JC. Sensory neuronopathies, diagnostic criteria and causes. Curr Opin Neurol 2022. [PMID: 35950727 DOI: 10.1097/WCO.0000000000001105] [Reference Citation Analysis]
5 Mahroum N, Elsalti A, Alwani A, Seida I, Alrais M, Seida R, Esirgun SN, Abali T, Kiyak Z, Zoubi M, Shoenfeld Y. The mosaic of autoimmunity - Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens. Autoimmun Rev 2022;:103166. [PMID: 35932955 DOI: 10.1016/j.autrev.2022.103166] [Reference Citation Analysis]
6 Kaida K. Dysautonomia in immune‐mediated neuropathies. Neurology & Clinical Neurosc 2022;10:124-129. [DOI: 10.1111/ncn3.12529] [Reference Citation Analysis]
7 Kaminsky A, Camdessanché J. Neuropatie sensitive. EMC - Neurologia 2022;22:1-7. [DOI: 10.1016/s1634-7072(21)46002-2] [Reference Citation Analysis]
8 Theuriet J, Pegat A, Bernard E, Richard C, Camdessanche J, Vukusic S. Acute relapsing ataxic sensory neuronopathy with anti-FGFR3 autoantibodies mimicking acute myelopathy. Revue Neurologique 2022. [DOI: 10.1016/j.neurol.2021.11.015] [Reference Citation Analysis]
9 Tholance Y, Antoine JC, Mohr L, Jung M, Reynaud-Federspiel E, Ferraud K, Camdessanché JP, Moritz CP. Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern. J Neuroimmunol 2021;361:577757. [PMID: 34768040 DOI: 10.1016/j.jneuroim.2021.577757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chan ACY, Wong HY, Chong YF, Lai PS, Teoh HL, Ng AYY, Hung JHM, Chan YC, Ng KWP, Vijayan J, Ong JJY, Chandra B, Tan CH, Rutt NH, Tan TM, Ismail NH, Wilder-Smith E, Schwarz H, Choi H, Sharma VK, Mak A. Novel Autoantibodies in Idiopathic Small Fiber Neuropathy. Ann Neurol 2022;91:66-77. [PMID: 34761434 DOI: 10.1002/ana.26268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dalakas MC. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. Neurotherapeutics 2021. [PMID: 34766257 DOI: 10.1007/s13311-021-01108-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
12 Antoine J. Les neuronopathies sensitives dysimmunes : enjeux diagnostiques et thérapeutiques. Bulletin de l'Académie Nationale de Médecine 2021;205:937-945. [DOI: 10.1016/j.banm.2021.05.017] [Reference Citation Analysis]
13 Créange A. Physiopathologie et classification des neuropathies inflammatoires. Bulletin de l'Académie Nationale de Médecine 2021;205:926-936. [DOI: 10.1016/j.banm.2021.05.018] [Reference Citation Analysis]
14 Gemignani F, Bellanova MF, Saccani E, Pavesi G. Non-length-dependent small fiber neuropathy: Not a matter of stockings and gloves. Muscle Nerve 2021. [PMID: 34374103 DOI: 10.1002/mus.27379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Do LD, Moritz CP, Muñiz-Castrillo S, Pinto AL, Tholance Y, Brugiere S, Couté Y, Stoevesandt O, Taussig MJ, Rogemond V, Vogrig A, Joubert B, Ferraud K, Camdessanché JP, Antoine JC, Honnorat J. Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases. Neurol Neuroimmunol Neuroinflamm 2021;8:e1032. [PMID: 34321331 DOI: 10.1212/NXI.0000000000001032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fujii T, Lee EJ, Miyachi Y, Yamasaki R, Lim YM, Iinuma K, Sakoda A, Kim KK, Kira JI. Antiplexin D1 Antibodies Relate to Small Fiber Neuropathy and Induce Neuropathic Pain in Animals. Neurol Neuroimmunol Neuroinflamm 2021;8:e1028. [PMID: 34099459 DOI: 10.1212/NXI.0000000000001028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Sahi N, Ghasemi M, Rajabally YA. Autoantibodies in the diagnostic work-up of neuropathy: clinically useful or purely academic? British Journal of Neuroscience Nursing 2021;17:84-89. [DOI: 10.12968/bjnn.2021.17.3.84] [Reference Citation Analysis]
18 Trevino JA, Novak P. TS‐HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia. Muscle & Nerve 2021;64:70-6. [DOI: 10.1002/mus.27245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
19 Nagarajan E, Kang SA, Holmes C, Govindarajan R. Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study. BMC Neurol 2021;21:74. [PMID: 33588772 DOI: 10.1186/s12883-021-02090-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Vucic S. Advances in the understanding of sensory neuronopathies. J Neurol Neurosurg Psychiatry 2021:jnnp-2020-325999. [PMID: 33563797 DOI: 10.1136/jnnp-2020-325999] [Reference Citation Analysis]
21 Fargeot G, Echaniz-laguna A. Sensory neuronopathies: new genes, new antibodies and new concepts. J Neurol Neurosurg Psychiatry 2021;92:398-406. [DOI: 10.1136/jnnp-2020-325536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
22 Moritz CP, Stoevesandt O, Tholance Y, Camdessanché JP, Antoine JC. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection. N Biotechnol 2021;60:168-72. [PMID: 33045420 DOI: 10.1016/j.nbt.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tholance Y, Moritz CP, Camdessanché JP, Antoine JC. What is the pattern of the neuropathy associated with anti‐FGFR3 antibodies? Eur J Neurol 2020;27. [DOI: 10.1111/ene.14376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kira J. 5) The Cutting Edge of Pathomechanism and Therapy for Intractable Neuroimmunological Diseases. J Jpn Soc Intern Med 2020;109:1764-1774. [DOI: 10.2169/naika.109.1764] [Reference Citation Analysis]
25 Sahi N, Ghasemi M, Rajabally YA. Autoantibodies in the diagnostic work-up of neuropathy: clinically useful or purely academic? Br J Hosp Med (Lond) 2020;81:1-9. [PMID: 32730155 DOI: 10.12968/hmed.2020.0085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Roy B, Kovvuru S, Castillo YC, Huttner A, Nowak RJ. Reply to: What is the pattern of the neuropathy associated with anti-FGFR3 antibodies? Eur J Neurol 2020;27:e59. [PMID: 32503081 DOI: 10.1111/ene.14381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Martinez ARM, de Lima FD, Martins MP, Pereira IE, Miotto N, Mazo DFC, Vigani AG, da Costa LBE, Stucchi RSB, Almeida JRS, Nucci A, França MC Jr. Sensory neuronopathy is a specific and disabling neurological manifestation of autoimmune hepatitis. Eur J Neurol 2020;27:2072-8. [PMID: 32441838 DOI: 10.1111/ene.14355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Mathis S, Duval F, Soulages A, Solé G, Le Masson G. The ataxic neuropathies. J Neurol 2021;268:3675-89. [DOI: 10.1007/s00415-020-09994-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Tiwana HK, Lawson VH. Green shoots but deep roots: New antibodies in small fiber neuropathy. Muscle Nerve 2020;61:433-435. [DOI: 10.1002/mus.26818] [Reference Citation Analysis]
30 Kovvuru S, Cardenas YC, Huttner A, Nowak RJ, Roy B. Clinical characteristics of fibroblast growth factor receptor 3 antibody-related polyneuropathy: a retrospective study. Eur J Neurol 2020;27:1310-8. [PMID: 32068339 DOI: 10.1111/ene.14180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
31 Latov N. FGFR3 autoantibodies in sensory neuronopathy. J Neurol Neurosurg Psychiatry 2019;91:8-8. [DOI: 10.1136/jnnp-2019-322081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]